Patents by Inventor Jennifer Bolton

Jennifer Bolton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7981931
    Abstract: The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.
    Type: Grant
    Filed: December 2, 2009
    Date of Patent: July 19, 2011
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Jennifer Bolton
  • Patent number: 7939689
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Grant
    Filed: March 10, 2009
    Date of Patent: May 10, 2011
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Publication number: 20110086881
    Abstract: The invention relates to crystalline free base forms of biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. This invention also relates to pharmaceutical compositions containing or prepared from such crystalline forms; processes and intermediates useful for preparing such crystalline forms; and methods of using such crystalline forms to, for example, treat a pulmonary disorder.
    Type: Application
    Filed: December 16, 2010
    Publication date: April 14, 2011
    Applicant: THERAVANCE, INC.
    Inventors: Jennifer BOLTON, Robert S. CHAO, Miroslav RAPTA, Lisa WILLIAMS, Richard D. WILSON
  • Patent number: 7880010
    Abstract: The invention relates to crystalline free base forms of biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. This invention also relates to pharmaceutical compositions containing or prepared from such crystalline forms; processes and intermediates useful for preparing such crystalline forms; and methods of using such crystalline forms to, for example, treat a pulmonary disorder.
    Type: Grant
    Filed: April 24, 2007
    Date of Patent: February 1, 2011
    Assignee: Theravance, Inc.
    Inventors: Jennifer Bolton, Robert S. Chao, Miroslav Rapta, Lisa Williams, Richard D. Wilson
  • Patent number: 7790766
    Abstract: The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.
    Type: Grant
    Filed: July 21, 2004
    Date of Patent: September 7, 2010
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Jennifer Bolton
  • Publication number: 20100076079
    Abstract: The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.
    Type: Application
    Filed: December 2, 2009
    Publication date: March 25, 2010
    Inventors: Thomas E. Jenkins, Jennifer Bolton
  • Publication number: 20090253787
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Application
    Filed: March 10, 2009
    Publication date: October 8, 2009
    Applicant: THERAVANCE, INC.
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Patent number: 7514425
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Grant
    Filed: January 13, 2006
    Date of Patent: April 7, 2009
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Publication number: 20070249674
    Abstract: The invention relates to crystalline free base forms of biphenyl-2-ylcarbamic acid 1-[2-(4-{[(R)-2-(3-formylamino-4-hydroxyphenyl)-2-hydroxyethylamino]methyl}-2,5-dimethylphenylcarbamoyl)ethyl]piperidin-4-yl ester or a solvate thereof. This invention also relates to pharmaceutical compositions containing or prepared from such crystalline forms; processes and intermediates useful for preparing such crystalline forms; and methods of using such crystalline forms to, for example, treat a pulmonary disorder.
    Type: Application
    Filed: April 24, 2007
    Publication date: October 25, 2007
    Inventors: Jennifer Bolton, Robert S. Chao, Miroslav Rapta, Lisa Williams, Richard D. Wilson
  • Patent number: 7226946
    Abstract: The invention provides substituted phenol compounds and pharmaceutical compositions containing substituted phenol compounds which are useful for inducing or maintaining anesthesia or sedation in a mammal. This invention also provides methods for inducing or maintaining anesthesia or sedation in a mammal using substituted phenol compounds.
    Type: Grant
    Filed: August 27, 2004
    Date of Patent: June 5, 2007
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Yu-Hua Ji, Huiwei Wu, Jennifer Bolton
  • Publication number: 20060116424
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Application
    Filed: January 13, 2006
    Publication date: June 1, 2006
    Inventors: Thomas Jenkins, Sabine Axt, Jennifer Bolton
  • Patent number: 7015346
    Abstract: The invention provides a process for preparing a compound useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Grant
    Filed: November 3, 2004
    Date of Patent: March 21, 2006
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Publication number: 20050113364
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Application
    Filed: November 3, 2004
    Publication date: May 26, 2005
    Inventors: Thomas Jenkins, Sabine Axt, Jennifer Bolton
  • Patent number: 6887866
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Grant
    Filed: January 24, 2003
    Date of Patent: May 3, 2005
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Publication number: 20050032753
    Abstract: The invention provides substituted phenol compounds and pharmaceutical compositions containing substituted phenol compounds which are useful for inducing or maintaining anesthesia or sedation in a mammal. This invention also provides methods for inducing or maintaining anesthesia or sedation in a mammal using substituted phenol compounds.
    Type: Application
    Filed: August 27, 2004
    Publication date: February 10, 2005
    Inventors: Thomas Jenkins, Yu-Hua Ji, Huiwei Wu, Jennifer Bolton
  • Publication number: 20050020674
    Abstract: The invention provides pharmaceutical compositions comprising a phenylacetic acid ester compound useful for inducing or maintaining general anesthesia or sedation in mammals, methods for preparing such compositions, and methods for inducing or maintaining anesthesia or sedation using such compositions.
    Type: Application
    Filed: July 21, 2004
    Publication date: January 27, 2005
    Inventors: Thomas Jenkins, Jennifer Bolton
  • Patent number: 6815555
    Abstract: The invention provides substituted phenol compounds and pharmaceutical compositions containing substituted phenol compounds which are useful for inducing or maintaining anesthesia or sedation in a mammal. This invention also provides methods for inducing or maintaining anesthesia or sedation in a mammal using substituted phenol compounds.
    Type: Grant
    Filed: September 26, 2002
    Date of Patent: November 9, 2004
    Assignee: Theravance, Inc.
    Inventors: Thomas E. Jenkins, Yu-Hua Ji, Huiwei Wu, Jennifer Bolton
  • Publication number: 20030153554
    Abstract: The invention provides compounds compositions and methods useful for inducing or maintaining general anesthesia or sedation in mammals.
    Type: Application
    Filed: January 24, 2003
    Publication date: August 14, 2003
    Inventors: Thomas E. Jenkins, Sabine Axt, Jennifer Bolton
  • Publication number: 20030119790
    Abstract: The invention provides substituted phenol compounds and pharmaceutical compositions containing substituted phenol compounds which are useful for inducing or maintaining anesthesia or sedation in a mammal. This invention also provides methods for inducing or maintaining anesthesia or sedation in a mammal using substituted phenol compounds.
    Type: Application
    Filed: September 26, 2002
    Publication date: June 26, 2003
    Inventors: Thomas E. Jenkins, Yu-Hua Ji, Huiwei Wu, Jennifer Bolton